Trustlife Therapeutics UK - Innovative Drug Development Platform
Trustlife R&D Center in Turkey – Strong Pre-Clinical Lab Capabilities
Key Facts
- R&D Center Certified by the Turkish Ministry of Science & Technology
- 1,500 sqm enclosed area
- Total capex spent - USD 4M
- 45 highly qualified scientists
- Lab capacity for 13 simultaneous Preclinical studies
- All data produced in our R&D centers are verified and confirmed with external research centers (KTH @Sweden, King's @UK, Chieti Pescara University @Italy)
- Also exporting scientific services to Swedish & US companies
- Project (drug candidate) selection process by an independent selection panel including highly qualified international scientists
- Detailed scientific progress monitoring & risk mitigation plans reviewed in bi-weekly update meetings
- Funding for projects released / managed based on scientific and operational KPIs
Capabilities
Medicinal Chemistry Laboratory – 20 PhD, 8 MSc, 2 BSc
- 27 Medicinal Chemistry Synthesis Station
- Innovative molecular analytical characterization
- Design and implementation of Green Chemistry synthesis strategy
Cell Tissue Culture Laboratory – 3 PhD, 3 MSc
- 4 Cell and Tissue Culture Station
- Cell models of different diseases
- Bicompability tests
Computational Chemistry / Biology Laboratory – 6 PhD
- New compound design through computer-based modelling techniques
Formulation Laboratory – 2PhD, 1 MSc
- Development of medicine formulation for pre-clinical and clinical studies
- Increasing cell permeability
- Ensuring the blood-brain barrier passage
